Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-24

FDA Approved: PITAVASTATIN — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA granted a supplemental approval for a generic pitavastatin product from Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pitavastatin (Pitavastatin)

Snippet

SUPPL AP for PITAVASTATIN (PITAVASTATIN)